Literature DB >> 6582998

Granulocytic sarcoma treated as an acute leukemia. Report of a case.

T M Beck, J C Day, C E Smith, H E Eddy.   

Abstract

A young man presented with intestinal obstruction. Laparotomy revealed a large mass encircling the cecum and terminal ileum which histologically proved to be a granulocytic sarcoma. No evidence of leukemia was present in peripheral blood or bone marrow. Initial therapy consisted of abdominal irradiation. Two months following completion of irradiation, widespread systemic involvement without leukemia was evident. Systemic chemotherapy with doxorubicin, cytosine arabinoside, vincristine, and prednisone was initiated. Chemotherapy was continued for 18 months. The patient has remained without evidence of disease for 49 months following discontinuation of treatment, and 67 months after initial diagnosis. Systemic therapy for granulocytic sarcoma presenting without evidence of leukemia is reviewed.

Entities:  

Mesh:

Year:  1984        PMID: 6582998     DOI: 10.1002/1097-0142(19840415)53:8<1764::aid-cncr2820530825>3.0.co;2-q

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

1.  Granulocytic sarcoma of the cervix: an immunohistochemical, histochemical, and ultrastructural study.

Authors:  S Banik; A B Grech; B P Eyden
Journal:  J Clin Pathol       Date:  1989-05       Impact factor: 3.411

2.  Successful treatment of a granulocytic sarcoma of the uterine cervix in complete remission at six-year follow-up.

Authors:  Stefano C H Kim; Shanti Natarajan-Ame; Bruno Lioure; Marie-Pierre Chenard; Brigitte Duclos; Raoul Herbrecht; Jean-Pierre Bergerat
Journal:  J Oncol       Date:  2010-04-29       Impact factor: 4.375

3.  Granulocytic sarcoma: a diagnosis to be considered in unusual lymphoma syndromes.

Authors:  J L Mansi; P J Selby; R L Carter; R L Powles; T J McElwain
Journal:  Postgrad Med J       Date:  1987-06       Impact factor: 2.401

4.  T-lymphocyte sub-populations in orbito-ocular granulocytic sarcoma (OOGS) and acute myelocytic leukemia (AML): a preliminary study.

Authors:  A O Cavdar; E Babacan; S Gözdasoglu; G Yavuz; E Unal; A Pamir
Journal:  Med Oncol Tumor Pharmacother       Date:  1993
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.